Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors

Journal of Experimental Medicine

Volumn 186, Issue 9, 1997, Pages 1591-1596

  Ruby, Janet ^a,b   Bluethmann, Horst ^c   Peschon, Jacques J ^d  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Pharma Research   (Switzerland)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P55; PROTEIN P75; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ECTROMELIA VIRUS; FEMALE; GENE DISRUPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS ATTENUATION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; ECTROMELIA, INFECTIOUS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINATION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION;

EID: 0030722084     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.9.1591     Document Type: Article

References (39)

1. Wong, G.H., and D.V. Goeddel. 1986. Tumour necrosis factors α and β inhibit virus replication and synergise with interferons. Nature (Lond.). 323:819-822.
2. Wong, G.H., J.F. Krowka, D.P. Stites, and D.V. Goeddel. 1988. In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-α and interferon-γ. J. Immunol. 140: 120-124.
3. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohm, A. Moller, H. Jacobsen, and H. Kirchner. 1986. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature (Lond.). 323:816-819.
4. Lucin, P., S. Jonjic, M. Messerle, B. Polic, H. Hengel, and U.H. Koszinowski. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J. Gen. Virol. 75: 101-110.
5. Sambhi, S.K., M.R.J. Kohonen-Corish, and I.A. Ramshaw. 1991. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc. Natl. Acad. Sci. USA. 88:4025-4029.
6. Anderson, K., Y. Lie, M. Low, and E. Fennie. 1993. Effects of tumor necrosis factor-alpha treatment on mortality in murine cytomegalovirus-infectcd mice. Antivir. Res. 21:343-355.
7. Heise, M., and H. Virgin. 1995. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:904-909.
8. Pavic, I., B. Polic, I. Crnkovic, P. Lucin, S. Jonjic, and U.H. Koszinowski. 1993. Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection. J. Gen. Virol. 74:2215-2223.
9. Peper, R., and H. Van Campen. 1995. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb. Pathog. 19:175-183.
10. Leist, T.P., and R.M. Zinkernagel. 1990. Treatment with anti-tumor necrosis factor alpha does not influence the immune pathological response against lymphocytic choriomeningitis virus. Cytokine. 2:29-34.
11. Yamada, T., A. Matsumori, and S. Sasayama. 1994. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation. 89:846-851.
12. Smith, C., T. Davis, J. Wignall, W. Din, T. Farrah, C. Upton, G. McFadden, and R. Goodwill. 1991. T2 open reading frame from the Shope Fibroma Virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 176: 335-342.
13. Upton, C., J.L. Macen, M. Schreiber, and G. McFadden. 1991. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to virus virulence. Virology. 184:370-382.
14. McFadden, G. 1994. DNA viruses that affect cytokine networks. In Human Cytokines: Their Role in Health and Dis ease. B.B. Aggarwal and R.K. Puri, editors. Blackwell Press, Cambridge, MA. 403-422.
15. Wold, W.S. 1993. Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF. J. Cell. Biochem. 53:329-335.
16. Bertin, J., R. Armstrong, S. Ottilie, D. Martin, Y. Wang, S. Banks, G.-H. Wang, T. Senkevitch, E. Alnemri, B. Moss, et al. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:1172-1176.
17. Aggarwal, B.B., and K. Natarajan. 1996. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:93-124.
18. Wong, G.H., L.A. Tartaglia, M.S. Lee, and D.V. Goeddel. 1992. Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor. J. Immunol. 149: 3350-3353.
19. Rothe, J., F. Mackay, H. Bluethmann. R. Zinkernagel, and W. Lesslauer. 1994. Phenotypic analysis of TNFR 1-deficient mice and characterization of INFR 1-deficient fibroblast in vitro. Circ. Shock. 44:51-56.
20. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated cytotoxicity but highly susceptible to infection by Listeria monocytogenes. Nature (Lond.). 364:798-802.
21. Zheng, L., G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature (Lond.). 377:348-351.
22. Bruce, A.J., W. Boling, M.S. Kindy, J.J. Peschon, P.J. Kraemer, M.K. Carpenter, F.W. Holtsberg, and M.P. Mattson. 1996. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2:788-794.
23. Matsumoto, M., S. Mariathasan, M.H. Nahm, F. Baranyay, J.J. Peschon, and D.D. Chaplin. 1996. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science (Wash. DC). 271:1289-1291.
24. Ramshaw, I.A., M.E. Andrew, S.M. Phillips, D.H. Boyle, and B.E.H. Coupar. 1987. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection. Nature (Lond.). 329:545-546.
25. + T cells is dependent on interferon-γ. Lymphokine Cytokine Res. 10:353-358.
26. Mohler, K., D. Torrance, C.A. Smith, R.G. Goodwin, K.E. Stremler, V.P. Fung, H. Madani, and M.B. Widmer. 1993. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1548-1561.
27. Karupiah, G., T.N. Fredrickson, K.L. Holmes, L.H. Khairallah, and R.M.L. Buller. 1993. Importance of interferons in recovery from mousepox. J. Virol. 67:4214-4226.
28. Fenner, F. 1949. Mousepox (infectious ectromelia of mice): a review. J. Immunol. 63:341-373.
29. Bhatt, P.N., R.O. Jacoby, and L. Gras. 1988. Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. IV. Studies with the Moscow strain. Arch. Virol. 100:221-230.
30. + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70:8301-8309.
31. van den Brock, M.F., U. Muller, S. Huang, M. Aguet, and R.M. Zinkernagel. 1995. Antiviral defense in mice lacking both alpha beta and gamma interferon receptors. J. Virol. 69: 4792-4796.
32. Howard, S., Y. Chan, and G. Smith. 1991. Vaccinia virus homologues of the Shope Fibroma Virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology. 180:633-647.
33. Tartaglia, L., D. Pennica, and D. Goeddel. 1994. Liquid passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268:18542-18548.
34. Bigda, J., I. Beletsky, C. Brakebusch, Y. Varfolomeev, H. Engelmann, J. Bigda, H. Holtmann, and D. Wallach. 1994. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med. 180:445-460.
35. L on activated T cells and can be prevented by CD28 costimulation. J. Immunol. 158:598-603.
36. Sheehan, K.C.F., J.K. Pinckard, C.D. Arthur, L.P. Dehner, D.V. Goeddel, and R.D. Schreiber. 1995. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75. J. Exp. Med. 181:607-617.
37. Weiss, T., M. Grell, B. Hessabi, S. Bourteele, G. Muller, P. Scheurich, and H. Wajant. 1997. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80. Requirement of the TNF receptor-associated factor-2 binding site. J. Immunol. 158:2398-2404.
38. Pinckard, J.K., K.C.F. Sheehan, and R.D. Schreiber. 1997. Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells. J. Biol. Chem. 272:10784-10789.
39. Grell, M., E. Douni. H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 83:793-802.